A Molecular Basis for MHC Class II—Associated Autoimmunity

John A. Todd(John Radcliffe Hospital), Hans Acha‐Orbea(Stanford University), John I. Bell(John Radcliffe Hospital), Nelson J. Chao(Stanford University), Zdenka Fronek(Stanford University), Chaim O. Jacob(Stanford University), Michael McDermott(Stanford University), Animesh A. Sinha(Stanford University), Luika Timmerman(Stanford University), Lawrence Steinman(Stanford University), Hugh O. McDevitt(Stanford University)
Science
May 20, 1988
Cited by 708

Abstract

Class II major histocompatibility (MHC) molecules have an immunoregulatory role. These cell-surface glycoproteins present fragments of protein antigens (or peptides) to thymus-derived lymphocytes (T cells). Nucleotide sequence polymorphism in the genes that encode the class II MHC products determines the specificity of the immune response and is correlated with the development of autoimmune diseases. This study identifies certain class II polymorphic amino acid residues that are strongly associated with susceptibility to insulin-dependent diabetes mellitus, rheumatoid arthritis, and pemphigus vulgaris. These findings implicate particular class II MHC isotypes in susceptibility to each disease and suggest new prophylactic and therapeutic strategies.


Related Papers

No related papers found

Powered by citation graph analysis